adenosine 5'-methylenediphosphate has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobelmann, C; Idris, RM; Irjala, H; Jacobson, KA; Junker, A; Keim, A; Losenkova, K; Moschütz, S; Müller, CE; Oliva, P; Salmaso, V; Sandholm, J; Scortichini, M; Sträter, N; Vaittinen, S; Yegutkin, GG | 1 |
| Miao, Z; Wang, C; Wang, Y; Wu, Y; Ye, S; Zhang, H; Zhang, Y; Zhu, Y | 1 |
2 other study(ies) available for adenosine 5'-methylenediphosphate and Neoplasms
| Article | Year |
|---|---|
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
Topics: 5'-Nucleotidase; Adult; Cytosine Nucleotides; Diphosphonates; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Neoplasms; Palatine Tonsil; Protein Binding; Structure-Activity Relationship | 2022 |
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors.
Topics: 5'-Nucleotidase; Adenosine; Betulinic Acid; Humans; Immunotherapy; Neoplasms; Pentacyclic Triterpenes | 2022 |